A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne Vulgaris
Clinical trial NCT01019603 · COMPLETED
Trial details
- NCT number
- NCT01019603
- Sponsor
- Stiefel, a GSK Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-12
- Primary completion
- 2009-12-20
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.